Actigraphy Devices Market — By Product, By Application, By Distribution Channel – Global Forecast, 2025 to 2034

Actigraphy Devices Market Size

The global actigraphy devices market was valued at USD 2.3 billion in 2024. The market is expected to grow from USD 2.4 billion in 2025 to USD 4.2 billion in 2034, at a CAGR of 6.4%. As more people and healthcare providers seek non-invasive ways to monitor health in real-time, actigraphy devices are becoming increasingly popular. The growing use of AI-powered analytics and remote patient monitoring is also improving the accuracy and efficiency of these assessments, making them more valuable in clinical and personal health settings. This shift is driving steady market growth.
 

Sleep disorders such as insomnia, sleep apnea, RLS, and circadian rhythm disorders are becoming more prevalent. People are becoming more prone to stress, lifestyle changes, and excessive screen time, which are key factors. According to June 2023 study from the National Center for Biotechnology Information, around 50-70 million people in the U.S. suffer from some form of sleep dysfunction that interferes with their day-to-day productivity and adversely affects their health. Sleep deprivation is associated with heart disease, heart failure, obesity, diabetes, and even more negative mental disorders such as anxiety and depression.
 

These patients as well as health care practitioners are constantly trying to find methods to monitor sleep physiologically without the hassles of sleep tests. New Actigraphy devices are becoming the new norm as they offer a simple, cost effective way to track sleeping patterns. Unlike sleep studies which are conducted in labs, these devices are far more convenient and accessible for individuals seeking to improve their sleep hygiene.
 

Moreover, an increasing public ignorance regarding the impact of better sleep quality and its health consequences has become one of the primary driving forces of the market. With the growing wellness and self-care trend, more people strive to optimize their sleep and track it through wearable health gadgets. A smart wristband and fitness band, along with a mobile phone that can track sleep patterns, are utilized by a significant percentage of the population that are concerned about their sleep cycles. The modern era’s focus on self-analysis and health bio hacks is shifting consumer focus in the direction of advanced technologies which offer an in-depth diagnosis of various parameters on sleep efficiency, sleep onset, and other disturbances during sleep.
 

Actigraphy is the process of tracking and recording the sleep-wake cycle along with activities, which could be performed through a wearable or handheld device. These devices may detect motion and translate motion data into relevant information used for counting sleep, assessing sleep disorders, rhythm sleep disturbances, and various mental health conditions. Clinical research and psychiatric assessments are where actigraphy is mostly applied, alongside patient monitoring outside of clinical settings, enabling sleep pattern data collection beyond controlled environments.
 

Actigraphy Devices Market Trends

• The unprecedented growth of the market is linked to technological advancements in sleep medicine, the greater prevalence of sleep-related health issues, and the adoption of wearable health tracking devices. The most prevalent trend in this market is the application of artificial intelligence (AI) and machine learning (ML) technologies in the monitoring and analysis of sleep and circadian rhythms.
   
• With AI implementation in actigraphy, there is an improvement in outlier detection, general accuracy, and allocation of sleep interventions to improve sleep quality. Companies such as Fitbit, Apple, and Garmin are developing advanced sleep monitoring features for their wristwatch style devices which require AI integration. There is a growing demand for personalization of real-time health information data which mandates most manufacturers to equip their devices with advanced analytics, predictive, and prescriptive modelling capabilities.
   
• The combination of actigraphy with other relevant technologies in wearables is also offering a significant potential. High interest in smartwatches, fitness bands, and AI powered sleep monitors has resulted in a decline in the use of traditional stand-alone actigraphy devices. Smart wearables track multiple biometrics including heart rate variability (HRV), oxygen levels (SpO2), and stress monitoring. These advancements in technology has changed consumer behaviour.
   
• Popularity in the integration of actigraphy and other biometric sensors in smart wearables such as Apple Watch, Fitbit Sense, and Oura Ring is on the rise. The technological progress in battery miniaturization and increased efficiency, together with other advancements, has made wearable actigraphy devices more convenient and accessible to the general public and healthcare professionals.
   
• Along with the increased focus on telemedicine and digital healthcare, the market is also driven by remote patient monitoring (RPM) and home-based sleep diagnostics. There is a shift from hospitals and sleep clinics toward portable and wearable actigraphy devices for continuous monitoring of sleep disorders and assessment of circadian rhythms due to increased focus on telemedicine and digital healthcare. These trends are most notable in the U.S., UK, and China, where governments and other healthcare stakeholders are funding the digital health infrastructure to improve diagnostic technology accessibility for patients.
   
• Moreover, the scope of actigraphy has expanded beyond sleep monitoring application. The implementation of actigraphy technology into monitoring mental health, depression, and research on neurodegenerative diseases advances the position of the technology as a clinically valuable diagnostic tool.
   

Actigraphy Devices Market Analysis

Based on product, the market is segmented into wearable actigraphy devices and handheld actigraphy devices. The wearable actigraphy devices segment continues to dominate, securing a substantial market size valued at USD 1.8 billion in 2024.
 

• Wearables unlike handheld devices offer effortless long-term sleep pattern monitoring which does not interfere with the user’s daily activities. The sector has greatly benefited from the increased sales of smartwatches and fitness bands that come with built-in sleep monitoring features.
   
• As a result, Fitbit, Garmin, Apple, and Samsung are vying to enhance users experience with wearable actigraphy devices by adding AI analytics, cloud infrastructures, and personalized sleep summaries. The implementation of smart features in wearable actigraphy devices have increased their use over handheld actigraphy devices for sleep monitoring, thus driving the growth of the segment.
   

Based on application, the actigraphy devices market is categorized into sleep disorders monitoring, circadian rhythm disorder monitoring, insomnia and restless leg syndrome diagnosis, and other applications. The sleep disorder monitoring segment held a dominant market share and accounted for USD 1 billion in 2024.
 

• Due to the high prevalence of sleep disorders, growing demand for diagnosing sleep disorders, and heightened knowledge of sleep health, the sleep disorder monitoring segment continues to dominate the market. As reported by the National Sleep Foundation, by May 2021, about 10-30% of adults are affected by insomnia and about 2-9% of adults struggle with obstructive sleep apnea. There has been increasing popularity of action-based sleep monitoring as a cost-effective and readily available alternative to PSG (polysomnography) in the field of sleep medicine. 
   
• In addition, the actigraphy devices have also been recognized as fundamental to routine wellness assessments which has increased the level of reimbursement for diagnostics based on actigraphy provided by health insurers and healthcare authorities. As a result, this has boosted the overall supply for products intended for the monitoring of sleep disorders, driving the revenue growth in the sleep disorder monitoring segment.
   

The actigraphy devices market by distribution channel is categorized into online, and brick and mortar. The online segment held a dominant market share and accounted for USD 1.4 billion in 2024.
 

• The availability of e-commerce websites has contributed to the expansion of direct sales (DTC) merchants which, in turn, has improved the online distribution channel. This in itself has resulted in Fitbit, Apple, and Garmin incorporating digital marketing strategies and online-exclusive sales to reach a wider audience.
   
• Online sales are also witnessing extensive growth due to the introduction of subscription-based sleep tracking services. Customers are able to purchase actigraphy devices through platforms like Amazon and Best Buy, as well as company-operated e-stores that offer discounted bundles and financing options.
   

U.S. actigraphy devices market accounted for USD 832.7 million revenue in 2024 and is anticipated to record robust market growth over the forecast period.
 

• The demand for actigraphy devices in the U.S. is driven by high prevalence of sleep disorders, advanced healthcare facilities, and high consumer awareness regarding sleep health. As reported in the July 2022 publication by American Psychological Association, more than 25 million adults aged 30-70 in the U.S. suffer from obstructive sleep apnea. This is increasing the need for wearables and clinical actigraphy devices. 
   
• Further, players like Apple, Fitbit, and Philips Healthcare are pioneering consumer-accessible AI-powered sleep tracking technologies, which increase the accessibility of actigraphy devices in the U.S. remote patient monitoring and increasing insurance coverage for sleep diagnostic tests are also contributing to the growth of the market in the U.S.
   

Europe: UK actigraphy devices market is projected to grow remarkably in the coming years.
 

• The adoption of smartwatches and fitness trackers that offer sleep monitoring capabilities has gained traction in the UK, further boosting the popularity of activity trackers. Consumer adoption has been dramatically enhanced through AI-based actigraphy created by Withings and Garmin. As per the survey results published by Statista, the ownership of wearable devices in UK remained at 37% in 2025, increasing from 19% in 2019.
   
• In addition, the spending increase among households for health-focused devices was supplemented by the government attempts to encourage sleep health promotion in the UK. The proactive diagnosis and treatment of sleep disorders enabled by NHS services has led to an increasing need for remote monitoring actigraphy devices.
   

China holds a dominant position in the Asia Pacific actigraphy devices market.
 

• The market for actigraphy devices in China is expanding rapidly due to high sales growth related to increased skin care awareness, high peripheral incomes, and better standards of e-commerce services in China. The increasing use of consumer electronics and government policies aimed at increasing the diagnosis rates of sleep disorders are active factors in the market development.
   
• Business leaders in telecommunication in China like Xiaomi and Huawei manufactures and designs cheap wearable portable actigraphy monitors. This widens the scope of the populations who can use sleep measuring devices. The market is further fueled by the growth of telemedicine and digital health services in the country.
   

Actigraphy Devices Market Share

The market for actigraphy devices is characterized by a mix of medical technology firms and wearable consumer electronics businesses. The top companies operating in the market are neurocare, Nox Medical, Philips Healthcare, ResMed, and Samsung that shares about 30% of the market. The market share competition is mostly balanced by product innovation, product portfolio diversification, and collaborations. Businesses holding FDA-approved clinically tested actigraphy devices are more competitive in the medical and research markets, while consumer brands focus on marketing AI features, simple interfaces, and multifunctional devices.
 

The major companies spend considerable resources on the research and development of their actigraphy devices, incorporating advanced technologies that enhance device accuracy and efficiency. The application of machine learning artificial intelligence, sleep tracking sensors, and real-time data analysis has become a strong competitive advantage. Other competitive advantages include the significant market share from active patents and proprietary technologies of tracking sleep due to the irresistible diagnostic accuracy and adoption from providers and consumers.
 

Strategic frameworks such as mergers, acquisitions, and joint ventures play a vital role in shaping the market's characteristics. In the recent times, large medical technology companies have acquired wearable health and digital health startups to gain more market share in the remote patient monitoring and sleep diagnostics sectors. In addition, partnerships with sleep clinics, hospitals, and telemedicine providers allow companies to strengthen their position in the market by implementing actigraphy based diagnostic devices into more advanced healthcare systems.
 

Adherence to law and regulatory certifications also influences the distribution of market shares. Companies who succeed in obtaining FDA approvals, CE markings, and other relevant international medical certifications are able to penetrate the permissive hospital, clinical test, and insurance subsidized reimbursement frameworks which gives them an edge over non-certified competitors. The rivals, on the other hand, target the mainstream market under consumer marketed brands which focus on health and fitness tracking, low-cost pricing, and compatibility with smart electronics.
 

Actigraphy Devices Market Companies

Prominent players operating in the actigraphy devices industry include:

• ActiGraph
• Advanced Brain Monitoring
• Apple
• CamNtech
• Cidelec
• Cleveland Medical Devices
• Fitbit
• Garmin
• neurocare
• Nox Medical
• Philips Healthcare
• ResMed
• Samsung
• SOMNOmedics
• Withings
   
• Fitbit, which is owned by Google, is among the most innovative companies in wearable actigraphy devices. The company’s smartwatches and fitness bands cover a wide range of health supervision including sleep tracking, AI-based sleep analysis, and sleep tracking systems. Fitbit’s gain in market competition is attributed to its additional SpO2 sensors and HRV monitoring capabilities which improve sleep disorder detection. 
   
• Apple offers complete monitoring of sleep, that includes sleep stage tracking, movement tracking, and circadian rhythm tracking through its Apple Watch, post upgrade with watchOS. The company announced in 2023 that it will incorporate sleep disorder prediction using machine learning algorithms expanding the clinical functionalities of its devices.
   
• Koninklijke Philips is creating clinically validated actigraphy devices for diagnosis and sleep disorder research. The Actiwatch series by Philips is widely utilized in rhythm disorders and insomnia clinical wards and clinical trials. In 2023, through collaborations with clinics and research institutions on automating data-driven management of sleep disorders, Philips Medical advanced its position in the sleep medicine grade actigraphy market. 
   
• Garmin in its health technology wearables, has integrated features of high-accuracy actigraphy into their Venu and Forerunner smartwatches. Their devices have also improved the monitoring of sleep, respiration, and stress which are of interest to many fitness and health consumers. Moreover, the company partnered with medical researchers to shift the focus from sleep to primary use of actigraphy in assessing mental health and depression. 
   

Actigraphy Devices Industry News:

• In January 2025, ActiGraph announced the acquisition of Biofourmis Connect, the life sciences division of Biofourmis. This strategic move aims to create a unified software and data ecosystem to modernize clinical research across various therapeutic areas.
   
• In February 2025, PranaQ announced to receive U.S. FDA 510(k) clearance for TipTraQ, a compact home sleep apnea test (HSAT) wearable that uses advanced biosensors and AI algorithms to detect sleep apnea events and analyze sleep architecture with clinical-grade accuracy. TipTraQ is a wearable device placed on the tip of the finger. A compact HSAT, TipTraQ leverages advanced biosensors and AI algorithms to identify sleep apnea events and assess sleep architecture with clinical-grade precision.
   
• In August 2023, Hyfe announced a partnership with ActiGraph, a provider of wearable digital health technology, to enhance clinical trials with advanced cough monitoring capabilities. This collaboration integrates Hyfe's Acoustic AI technology into ActiGraph's FDA-cleared LEAP device, enabling continuous monitoring of cough frequency and patterns alongside other health metrics such as sleep, mobility, heart rate, and oxygen saturation. This integration aims to provide a comprehensive view of patient health, particularly benefiting research in conditions where cough is a significant symptom, including chronic cough, COPD, congestive heart failure, and asthma.
   

Actigraphy devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD from 2021 to 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Wearable actigraphy devices
• Handheld actigraphy devices

Market, By Application

• Sleep disorders monitoring
• Circadian rhythm disorder monitoring
• Insomnia and restless leg syndrome diagnosis
• Other applications

Market, By Distribution Channel

• Online
• Brick and mortar

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE